Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
Study NCT ID:
NCT03822468
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2019-01-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-28
First Submit QC Date:
None
Study First Post Date:
2019-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-07
Results First Submit QC Date:
None
Results First Post Date:
2024-04-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-04-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED